Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17022725 | 0.86 | APEX1 (0.63) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL15691583 | 0.86 | APEX1 (0.63) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL29360310 | 0.85 | APEX1 (0.57) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL15691732 | 0.85 | APEX1 (0.57) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL17022624 | 0.83 | APEX1 (0.59) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL17022516 | 0.83 | APEX1 (0.55) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL17022643 | 0.83 | APEX1 (0.59) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL17022661 | 0.82 | APEX1 (0.54) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL15691720 | 0.81 | APEX1 (0.42) | APEX1SMN1; SMN2KMT2APDK2PRSS1 | |
| SCHEMBL17022542 | 0.79 | APEX1 (0.45) | APEX1SMN1; SMN2KMT2APRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3385300-B1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | MITSUBISHI CHEM CORP (JP) | 2020-12-30 | — | — | EP | disclosed |
| CN-106986748-B | Oligofluorenediols, oligofluorenediaryl esters, and methods for producing these | 三菱化学株式会社 | 2020-10-09 | — | — | CN | disclosed |
| EP-2910589-B1 | RESIN COMPOSITION, STRETCHED FILM , CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | MITSUBISHI CHEM CORP (JP) | 2019-09-11 | — | — | EP | disclosed |
| EP-3385300-A1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Mitsubishi Chemical Corporation (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-9518150-B2 | Resin composition, stretched film, circularly polarizing plate, and image display device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150247002-A1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-09-03 | — | — | US | disclosed |
| EP-2910589-A1 | RESIN COMPOSITION, STRETCHED FILM , CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Mitsubishi Chemical Corporation (JP) | 2015-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150247002-A1 | RESIN COMPOSITION, STRETCHED FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | RAD50, RAD54L, PUF60 | APEX1 3376/4885SMN1; SMN2 1621/4885KMT2A 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.